negative Schirmer's test. Scanning differentiated only poorly between the three groups. We conclude that it has only limited application in the diagnosis of SS associated with RA.
Salivary scanning is commonly used as an investigatory method to support the diagnosis of Sjogren's syndrome (SS) for both clinical and research purposes. Studies have shown its value in assessing xerostomia. 1-5 SS is one of the most frequent systemic complications of rheumatoid arthritis (RA), but the role of salivary scanning in defining this particular condition is still not clear. Early studies2 6 7 found it to be a sensitive, safe, and objective means of evaluating drying in RA, and these claims have subsequently been reiterated.i-5 8 The uptake and discharge values for the parotid glands are shown in Fig. 1 and the submandibular glands in Fig. 2 much less make a diagnosis in the individual patient. These findings do not support the widespread belief that scanning is a valuable tool in this situation and are more in conformity with the work of Kassan and Gardy"' and Katz et al. l l
The significant difference in submandibular uptake between groups 2 and 3 is not easily explained as neither of these groups had sicca symptoms, but there may be good theoretical reasons why uptake studies are an unreliable method of examining gland function. In the possibly analogous situation of thyroid scanning in hypothyroidism factors other than function may affect uptake results. These factors include total iodine pool, drugs, and even age. 13 Similar conditions could also apply to salivary gland uptake as it handles ions such as Tc in an identical fashion.'3 If this is so, then information of potentially greater value in the investigation of SS may well be obtained by studying in more detail the discharge phase of the salivary gland. 5 We conclude that salivary scanning is of little value in possible SS associated with RA whether to define large groups for research purposes or to diagnose this condition in an individual. 
